GLATIRAMER VIATRIS 40 mg/ml, solution for injection in a pre-filled syringe 12 syringes of 1 ml
Active ingredients: Glatiramer acetate, Glatiramer
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection12 syringes of 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLATIRAMER VIATRIS 40 mg/ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 12 seringue(s) préremplie(s) en verre de 1 ml
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Jun 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69849244CIP73012692CIP133400930126929Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE GLATIRAMÈREsolution | 40 mg · une seringue préremplie de 1 ml | SA |
| GLATIRAMÈRE BASEsolution | 36 mg · une seringue préremplie de 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.